Related Experiment Videos
[Immunosuppressive therapy. A survey concerning rationale, risks, indications and contraindications]
Ugeskrift for Laeger
|October 29, 1973
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Spongy lymphoid myelofibrosis as a predictor of hairy cell leukaemia or a variant of hairy cell leukaemia without hairy cells?
Scandinavian journal of haematology·1984
Prediction of survival in adults with acquired Bi- or pancytopenia.
Scandinavian journal of haematology·1984
Two additional cases of coexisting polycythaemia vera and chronic lymphocytic leukaemia.
Scandinavian journal of haematology·1982
Malignant centroblastic-histiocytic lymphoma of the skin.
Scandinavian journal of haematology·1982
The applicability of simple blood and bone marrow variables in prediction of acute leukaemia in patients with acquired bi- or pancytopenia.
Scandinavian journal of haematology·1981
[Endovascular treatment of iliofemoral venous thrombosis].
Ugeskrift for laeger·2026
[Lateral epicondylitis].
Ugeskrift for laeger·2026
[Infiltrating basal cell carcinoma with perineural growth in a 15-year-old].
Ugeskrift for laeger·2026
[Group A streptococcal toxic shock syndrome with influenza A and parapneumonic effusion].
Ugeskrift for laeger·2026
[The significance of frailty in the assessment of polypharmacy and deprescribing].
Ugeskrift for laeger·2026
[Nutrition in the prevention and treatment of frailty in older adults].
Ugeskrift for laeger·2026
The importance of B cells for osteogenic homeostasis.
Cell communication and signaling : CCS·2026
Leveraging chimeric antigen receptor-T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology.
Current research in translational medicine·2026
Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema.
Ophthalmology and therapy·2026
Double activation and low IL-2 manufacturing protocol increase expansion of healthy and patient-derived CAR-Tregs.
Molecular therapy. Advances·2026